Author:
Wu Yanhua,Pan Yuchen,Su Kaisheng,Zhang Yangyu,Jia Zhifang,Yi Jiaxin,Lv Haiyong,Zhang Lihuan,Xue Mingyang,Cao Donghui,Jiang Jing
Abstract
BackgroundThe COVID-19 pandemic brings great pressure to the public health systems. This meta-analysis aimed to compare the clinical outcomes among different virus variants, to clarify their impact on medical resources and to provide evidence for the formulation of epidemic prevention policies.MethodsA systematic literature search was performed in the PubMed, Embase, and Cochrane Library databases using the key words “Omicron” and “Delta.” The adjusted Risk ratios (RRs), Odds ratios (ORs) and Hazard ratios (HRs) were extracted, and RRs and Rate difference % (RD%) were used to interpret the risk estimates of the outcomes ultimately.ResultsForty-three studies were included, with 3,812,681 and 14,926,841 individuals infected with SARS-CoV-2 Delta and Omicron variant, respectively. The relative risks of hospitalization, death, ICU admission, and mechanical ventilation use after infection with the Omicron variant were all significantly reduced compared those after infection with the Delta variant (RRhospitalization = 0.45, 95%CI: 0.40–0.52; RRdeath = 0.37, 95%CI: 0.30–0.45; RRICU = 0.35, 95%CI: 0.29–0.42; RRmechanical ventilation = 0.33, 95%CI: 0.25–0.44). The change of both absolute and relative risks for hospitalization was more evident (RR = 0.47, 95%CI: 0.42–0.53;RD% =10.61, 95%CI: 8.64–12.59) and a significant increase was observed for the absolute differences in death in the elderly (RD% = 5.60, 95CI%: 4.65–6.55); the change of the absolute differences in the risk of hospitalization and death were most markedly observed in the patients with booster vaccination (RD%hospitalization = 8.60, 95CI%: 5.95–11.24; RD%death = 3.70, 95CI%: 0.34–7.06).ConclusionThe ability of the Omicron variant to cause severe clinical events has decreased significantly, as compared with the Delta variant, but vulnerable populations still need to be vigilant. There was no interaction between the vaccination doses and different variants.
Funder
Jilin University
Education Department of Jilin Province
Subject
Microbiology (medical),Microbiology
Reference69 articles.
1. Mortality risk among patients hospitalized primarily for COVID-19 during the omicron and Delta variant pandemic periods – United States, April 2020-June 2022;Adjei;MMWR Morb. Mortal. Wkly Rep.,2022
2. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19);Ahn;J. Microbiol. Biotechnol.,2020
3. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N. Engl. J. Med.,2022
4. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines;Araf;J. Med. Virol.,2022
5. BNT162b2 vaccine booster and mortality due to Covid-19;Arbel;N. Engl. J. Med.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献